New ventilation strategy aims to reduce lung damage in severe pneumonia
NCT ID NCT07679802
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study tests a new way of using a breathing machine (ventilator) called time-controlled adaptive ventilation (TCAV) in people with severe lung injury from pneumonia. The goal is to see if TCAV reduces fluid buildup in the lungs compared to standard ventilation. The trial involves 56 adults in the intensive care unit who need a breathing machine. If TCAV works, it could lead to better outcomes and fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Time-controlled adaptive ventilation (TCAV) using Airway Pressure Release Ventilation mode
What this could lead to
If effective, TCAV could offer a simple, low-cost way to reduce lung injury and improve survival in patients with severe respiratory failure.
What could go wrong
This is a small pilot study with 56 participants, so results may not apply broadly. The new ventilation method could also cause harm, such as worsening oxygen levels or kidney problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU de Nancy
Nancy, 54000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••